Hideki Kanemoto1, Yuto Satake2, Takashi Suehiro2, Daiki Taomoto2, Fuyuki Koizumi2, Shunsuke Sato2, Tamiki Wada2, Keiko Matsunaga3, Eku Shimosegawa3, Mamoru Hashimoto2,4, Kenji Yoshiyama2, Manabu Ikeda2. 1. Department of Psychiatry, Osaka University Graduate School of Medicine, D3 2-2 Yamadaoka, Suita, Osaka, 565-0871, Japan. hkanemoto@psy.med.osaka-u.ac.jp. 2. Department of Psychiatry, Osaka University Graduate School of Medicine, D3 2-2 Yamadaoka, Suita, Osaka, 565-0871, Japan. 3. Department of Molecular Imaging in Medicine, Osaka University Graduate School of Medicine, Osaka, Japan. 4. Department of Neuropsychiatry, Kindai University Faculty of Medicine, Sayama, Osaka, Japan.
Abstract
BACKGROUND: This study aimed to identify cases of potential prodromal DLB in very late-onset schizophrenia-like psychosis (VLOSLP), using indicative biomarkers of dementia with Lewy bodies (DLB), and to evaluate the characteristics of psychosis as prodromal DLB. METHODS: Data of patients with VLOSLP without dementia and Parkinsonism, who underwent testing for at least one indicative biomarker of DLB, were retrospectively collected from the database of the psychiatry clinic at the Osaka University Hospital. Patients were divided into two groups based on the positive (VLOSLP+LB) and negative (VLOSLP-LB) results of the indicative biomarkers of DLB. Age, gender, cognitive battery scores, prevalence of each type of delusions and hallucinations, cerebral volume, and cerebral perfusion were compared between the two groups. RESULTS: Eleven VLOSLP+LB and 23 VLOSLP-LB participants were enrolled. There were no significant differences in age, proportion of females, and MMSE scores between the two groups. The standardized score of the digit symbol substitution test was significantly lower in the VLOSLP+LB than in VLOSLP-LB group (6.9 [3.1] vs. 10.0 [2.7], p = 0.005). The prevalence of visual hallucinations was significantly higher in the VLOSLP+LB group than in the VLOSLP-LB group (81.8% vs. 26.1%, p = 0.003). Auditory hallucinations were prevalent in both groups (43.5% in VLOSLP-LB, and 45.5% in VLOSLP+LB). Among patients with auditory hallucinations, auditory hallucinations without coexistent visual hallucinations tended to be more prevalent in VLOSLP-LB (7 out of 10) than in VLOSLP+LB patients (1 out of 5). Although cerebral volume was not different in any region, cerebral perfusion in the posterior region, including the occipital lobe, was significantly lower in the VLOSLP+LB group. CONCLUSIONS: Psychomotor slowing, visual hallucinations, and reduced perfusion in the occipital lobe may be suggestive of prodromal DLB in VLOSLP patients, even though the clinical manifestations were similar in many respects between VLOSLP+LB and VLOSLP-LB. Although auditory hallucinations were prevalent in both groups, most patients in VLOSLP+LB complained of auditory hallucinations along with visual hallucinations. Future studies with a larger number of patients without selection bias are desirable.
BACKGROUND: This study aimed to identify cases of potential prodromal DLB in very late-onset schizophrenia-like psychosis (VLOSLP), using indicative biomarkers of dementia with Lewy bodies (DLB), and to evaluate the characteristics of psychosis as prodromal DLB. METHODS: Data of patients with VLOSLP without dementia and Parkinsonism, who underwent testing for at least one indicative biomarker of DLB, were retrospectively collected from the database of the psychiatry clinic at the Osaka University Hospital. Patients were divided into two groups based on the positive (VLOSLP+LB) and negative (VLOSLP-LB) results of the indicative biomarkers of DLB. Age, gender, cognitive battery scores, prevalence of each type of delusions and hallucinations, cerebral volume, and cerebral perfusion were compared between the two groups. RESULTS: Eleven VLOSLP+LB and 23 VLOSLP-LB participants were enrolled. There were no significant differences in age, proportion of females, and MMSE scores between the two groups. The standardized score of the digit symbol substitution test was significantly lower in the VLOSLP+LB than in VLOSLP-LB group (6.9 [3.1] vs. 10.0 [2.7], p = 0.005). The prevalence of visual hallucinations was significantly higher in the VLOSLP+LB group than in the VLOSLP-LB group (81.8% vs. 26.1%, p = 0.003). Auditory hallucinations were prevalent in both groups (43.5% in VLOSLP-LB, and 45.5% in VLOSLP+LB). Among patients with auditory hallucinations, auditory hallucinations without coexistent visual hallucinations tended to be more prevalent in VLOSLP-LB (7 out of 10) than in VLOSLP+LB patients (1 out of 5). Although cerebral volume was not different in any region, cerebral perfusion in the posterior region, including the occipital lobe, was significantly lower in the VLOSLP+LB group. CONCLUSIONS: Psychomotor slowing, visual hallucinations, and reduced perfusion in the occipital lobe may be suggestive of prodromal DLB in VLOSLP patients, even though the clinical manifestations were similar in many respects between VLOSLP+LB and VLOSLP-LB. Although auditory hallucinations were prevalent in both groups, most patients in VLOSLP+LB complained of auditory hallucinations along with visual hallucinations. Future studies with a larger number of patients without selection bias are desirable.
Authors: G D Pearlson; L Kreger; P V Rabins; G A Chase; B Cohen; J B Wirth; T B Schlaepfer; L E Tune Journal: Am J Psychiatry Date: 1989-12 Impact factor: 18.112
Authors: Alex Kørner; Ana Garcia Lopez; Lise Lauritzen; Per Kragh Andersen; Lars Vedel Kessing Journal: Int J Geriatr Psychiatry Date: 2009-01 Impact factor: 3.485
Authors: Robert Howard; Elizabeth Cort; Rosie Bradley; Emma Harper; Linda Kelly; Peter Bentham; Craig Ritchie; Suzanne Reeves; Waleed Fawzi; Gill Livingston; Andrew Sommerlad; Sabu Oomman; Ejaz Nazir; Ramin Nilforooshan; Robert Barber; Chris Fox; Ajay Verma Macharouthu; Pranathi Ramachandra; Vivek Pattan; John Sykes; Val Curran; Cornelius Katona; Tom Dening; Martin Knapp; Richard Gray Journal: Lancet Psychiatry Date: 2018-06-04 Impact factor: 27.083
Authors: Alan J Thomas; Paul Donaghy; Gemma Roberts; Sean J Colloby; Nicky A Barnett; George Petrides; Jim Lloyd; Kirsty Olsen; John-Paul Taylor; Ian McKeith; John T O'Brien Journal: Psychol Med Date: 2018-04-25 Impact factor: 7.723
Authors: Ian G McKeith; Tanis J Ferman; Alan J Thomas; Frédéric Blanc; Bradley F Boeve; Hiroshige Fujishiro; Kejal Kantarci; Cristina Muscio; John T O'Brien; Ronald B Postuma; Dag Aarsland; Clive Ballard; Laura Bonanni; Paul Donaghy; Murat Emre; James E Galvin; Douglas Galasko; Jennifer G Goldman; Stephen N Gomperts; Lawrence S Honig; Manabu Ikeda; James B Leverenz; Simon J G Lewis; Karen S Marder; Mario Masellis; David P Salmon; John Paul Taylor; Debby W Tsuang; Zuzana Walker; Pietro Tiraboschi Journal: Neurology Date: 2020-04-02 Impact factor: 9.910